Intravenous antithrombotic activity of a synthetic heparin pentasaccharide in a human serum induced stasis thrombosis model.
D000818:Animals; D004195:Disease Models, Animal; D005170:Factor X / Q000037:antagonists & inhibitors; D015951:Factor Xa; D006493:Heparin / Q000494:pharmacology*; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D009844:Oligosaccharides / Q000494:pharmacology*; D011516:Prothrombin / Q000037:antagonists & inhibitors; D011817:Rabbits; D013917:Thrombin / Q000378:metabolism; D013927:Thrombosis / Q000097:blood / Q000209:etiology / Q000517:prevention & control*
D009844:Oligosaccharides; C049714:IC 831423; D011516:Prothrombin; D005170:Factor X; C025337:Factor IIa; D006493:Heparin; D013917:Thrombin; D015951:Factor Xa